Clinical trial
Investigating STAT3 as a Driver of Pathology and Potential Therapeutic Target in Periodontitis
NCT05506098 is registered in ClinicalTrials.gov with University of Chile as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Investigating STAT3 as a Driver of Pathology and Potential Therapeutic Target in Periodontitis
- Lead sponsor
- University of Chile
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 20, 2019
- Completion date
- October 20, 2022
- Enrollment
- 28 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.